Institutional Ownership Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the 446 institutions that hold shares in the stock, with a total of 184 Million shares, which have been reported (via 13F filing form) to have a value of $12.2 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
684,277
shares
|
$45.4 Million
1.14% of portfolio
|
Q3 2025
Reduced 29.15%
|
|
|
Frontier Capital Management CO LLC
|
Nov 14, 2025 Q3 2025 |
659,633
shares
|
$43.8 Million
0.34% of portfolio
|
Q3 2025
Added 23.12%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
633,886
shares
|
$42.1 Million
0.01% of portfolio
|
Q3 2025
Added 25.69%
|
|
|
Catalio Capital Management, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
622,729
shares
|
$41.3 Million
5.98% of portfolio
|
Q3 2025
Reduced 32.87%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
598,237
shares
|
$39.7 Million
0.27% of portfolio
|
Q3 2025
New holding
|
|
|
First Turn Management, LLC
Del Mar, CA |
Nov 14, 2025 Q3 2025 |
589,729
shares
|
$39.2 Million
4.6% of portfolio
|
Q3 2025
Added 6.9%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2025 Q3 2025 |
584,296
shares
|
$38.8 Million
0.56% of portfolio
|
Q3 2025
Added 52.07%
|
|
|
Primecap Management CO
Pasadena, CA |
Nov 10, 2025 Q3 2025 |
576,370
shares
|
$38.3 Million
0.02% of portfolio
|
Q3 2025
Reduced 2.1%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2025 Q3 2025 |
513,263
shares
|
$34.1 Million
0.01% of portfolio
|
Q3 2025
Reduced 27.13%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
504,110
shares
|
$33.5 Million
0.01% of portfolio
|
Q3 2025
Added 22.38%
|
|
|
Clearbridge Investments, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
493,063
shares
|
$32.7 Million
0.02% of portfolio
|
Q3 2025
Added 166.86%
|
|
|
Victory Capital Management Inc
|
Nov 12, 2025 Q3 2025 |
479,680
shares
|
$31.8 Million
0.02% of portfolio
|
Q3 2025
Added 41.97%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Oct 09, 2025 Q3 2025 |
473,496
shares
|
$31.4 Million
0.03% of portfolio
|
Q3 2025
Added 1.02%
|
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
462,311
shares
|
$30.7 Million
0.29% of portfolio
|
Q3 2025
Reduced 0.66%
|
|
|
Boone Capital Management LLC
Atlanta, GA |
Nov 14, 2025 Q3 2025 |
460,282
shares
|
$30.6 Million
7.84% of portfolio
|
Q3 2025
New holding
|
|
|
Nomura Holdings Inc
Tokyo, M0 |
Nov 14, 2025 Q3 2025 |
432,082
shares
|
$28.7 Million
0.04% of portfolio
|
Q3 2025
Added 59.38%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2025 Q3 2025 |
426,300
shares
|
$28.3 Million
0.01% of portfolio
|
Q3 2025
Reduced 4.32%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 03, 2025 Q3 2025 |
424,695
shares
|
$28.2 Million
0.04% of portfolio
|
Q3 2025
Added 53.0%
|
|
|
Emerald Mutual Fund Advisers Trust
|
Oct 30, 2025 Q3 2025 |
411,427
shares
|
$27.3 Million
1.22% of portfolio
|
Q3 2025
Reduced 36.29%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
402,926
shares
|
$26.8 Million
0.0% of portfolio
|
Q4 2024
Reduced 9.64%
|
|
|
Philosophy Capital Management LLC
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
385,000
shares
|
$25.6 Million
2.93% of portfolio
|
Q3 2025
Reduced 9.75%
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2025 Q3 2025 |
383,485
shares
|
$25.5 Million
0.02% of portfolio
|
Q3 2025
Added 35.15%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
383,178
shares
|
$25.4 Million
0.02% of portfolio
|
Q3 2025
Reduced 32.09%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
341,866
shares
|
$22.7 Million
0.0% of portfolio
|
Q3 2025
Reduced 46.13%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 13, 2025 Q3 2025 |
339,490
shares
|
$22.5 Million
0.0% of portfolio
|
Q3 2025
Added 112.75%
|
|